医療ウェアラブルの世界市場予測:デバイス別(バイタルサインモニタリング、血圧モニター、グルコースモニター、ECGモニター、パルス酸素濃度計)、製品別(スマートウォッチ、パッチ、リストバンド)、エンドユーザー別(病院、老人ホーム、外来)

◆英語タイトル:Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025
◆商品コード:MD 7653
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年5月29日
◆ページ数:163
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は医療ウェアラブルの世界市場が2020年74億ドルから2025年195億ドルまで、年平均21.4%%成長すると予測しています。本調査レポートでは、医療ウェアラブルの世界市場を詳細に調査・分析し、イントロダクション、調査手法、市場概要、市場インサイト、デバイスタイプ別(バイタルサインモニタリングデバイス、グルコースモニタリングデバイスとインスリンポンプ、胎児モニタリング&産科デバイス、デバイスニューロモニタリング、睡眠監視装置)、製品別(パッチ、スマートウォッチ、アクティビティモニター&リストバンド、その他臨床用ウェアラブル)、エンドユーザー別(長期ケアセンター、介護施設、ナーシングホーム、病院、外来診療センター、ホームケア設定)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・市場概要
・市場インサイト
・医療ウェアラブルの世界市場:デバイスタイプ別(バイタルサインモニタリングデバイス、グルコースモニタリングデバイスとインスリンポンプ、胎児モニタリング&産科デバイス、デバイスニューロモニタリング、睡眠監視装置)
・医療ウェアラブルの世界市場:製品別(パッチ、スマートウォッチ、アクティビティモニター&リストバンド、その他臨床用ウェアラブル)
・医療ウェアラブルの世界市場:エンドユーザー別(長期ケアセンター、介護施設、ナーシングホーム、病院、外来診療センター、ホームケア設定)
・医療ウェアラブルの世界市場:地域別
・競争状況
・企業概要
【レポートの概要】

“The medical wearables market is expected to grow at a CAGR of 21.4% during the forecast period.”
The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population and rising focus on patient-centric healthcare delivery.

“Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019.”
In 2019, the vital signs monitoring segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growing use of high-tech devices, which are compact, user-friendly, and come with a better graphical user interface for easy visibility of resulted data are helping to increase the market penetration of clinical-grade wearables. These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.

“Based on the product, the patches segment accounted for the largest share of the market in 2019.”
In 2019, the patches segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growth in the adoption of wearable technology is largely dependent on technological advancements and the ease of use. In the past few years, the clinical-grade wearables market has benefited from the growing penetration of 3G and 4G connections across the globe.

“Based on end-user, Long-term care centers, nursing homes, and assisted-living facilities segment is expected to show the highest growth during the forecast period.”
The long-term care centers, nursing homes, and assisted-living facilities segment is expected to show the highest growth during the forecast period. The highest growth of this segment can be attributed to the increasing number of people requiring long-term care as a result of the rising geriatric population and the increasing incidence of chronic disorders. Population aging is poised to become one of the most significant social transformations of the twenty-first century, with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services, such as housing, transportation and social protection, as well as family structures and intergenerational ties.

“By region, North America accounted for the largest market share in 2019.” In 2019, North America dominated the clinical-grade wearables market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America in the clinical-grade wearables market can be attributed to the high penetration of smartphones, tablets, and other mobile platforms, increasing prevalence of chronic diseases, development & adoption of innovative technologies, and rising government initiatives.

Breakdown of primary participants is as mentioned below:
• By Company Type: Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation: C-level: 45%, Director-level: 30%, and Others: 25%
• By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 5%, and Middle East & Africa: 5%
The prominent players in this market are Medtronic plc (Ireland), Apple, Inc. (US, DexCom Inc. (US), VitalConnect (US), Masimo Corporation (US), Koninklijke Philips N.V. (Netherlands), iRthym Technologies Inc.(US), Omron Corporation (Japan), BioTelemetry, Inc. (US), Bio-beat Technologies (Israel), GE Healthcare (US), Abbott Laboratories (US) and Vivalnk (US).
Research Coverage:
The report analyzes the clinical-grade wearables market and aims at estimating the current size and future growth potential based on various segments, such as product & service and region. It also covers competitive leadership mapping, which helps in analyzing the position of key market companies as visionary leaders, innovators, dynamic players, and emerging players. The report also provides a competitive analysis of the leading players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the clinical-grade wearables market. The report analyzes this market by product & service and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the clinical-grade wearables industry.
• Market Development: Comprehensive information on the lucrative emerging markets by product & service and region.
• Market Diversification: Exhaustive information about new testing services, recent developments, and investments in the clinical-grade wearables industry.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, and capabilities of leading players in the clinical-grade wearables market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 18)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 22)
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 TOP-DOWN APPROACH
2.2.2 GROWTH FORECAST
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION

3 MARKET OVERVIEW (Page No. – 42)
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Increasing awareness of fitness and incidence of lifestyle disorders
3.2.1.2 Advent of technologically advanced products
3.2.1.3 Growing geriatric population and incidence of chronic diseases
3.2.1.4 Cost-containment in healthcare delivery
3.2.1.5 Robust penetration of 3G and 4G networks for uninterrupted healthcare services
3.2.2 RESTRAINTS
3.2.2.1 Unfavorable standards and regulations
3.2.2.2 Accuracy, standardization, and analysis of wearable-generated data
3.2.3 OPPORTUNITIES
3.2.3.1 Growing adoption of mobile platforms
3.2.3.2 Increasing adoption of AI and 5G
3.2.4 CHALLENGES
3.2.4.1 Patent protection of clinical-grade wearables
3.2.4.2 Lack of data security and concerns over data theft and healthcare fraud
3.2.4.3 Limited battery life
3.2.4.4 Device design complexity

4 INDUSTRY INSIGHTS (Page No. – 48)
4.1 INDUSTRY TRENDS
4.2 ONCOLOGY – THE NEXT FRONTIER FOR CLINICAL-GRADE WEARABLES
4.3 FUTURE TRENDS IN CLINICAL-GRADE WEARABLES
4.4 INVESTMENTS IN CLINICAL-GRADE WEARABLE STARTUPS

5 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE (Page No. – 50)
5.1 INTRODUCTION
5.2 VITAL SIGN MONITORING DEVICES
5.2.1 MULTIPARAMETER TRACKERS
5.2.1.1 Increase in the prevalence of chronic diseases to drive this market segment
5.2.2 ECG/HOLTER/HEART RATE MONITORS
5.2.2.1 ECG monitors help improve the quality of care by facilitating the continuous monitoring of patients—a key factor driving market growth
5.2.3 BLOOD PRESSURE MONITORS
5.2.3.1 Clinical-grade wearable blood pressure monitors form a popular category as these devices are convenient to use and relatively less expensive
5.2.4 PULSE OXIMETERS
5.2.4.1 Growing adoption of pulse oximeters for self-monitoring purposes to drive growth in this market segment
5.3 GLUCOSE MONITORING DEVICES & INSULIN PUMPS
5.3.1 GROWTH IN THE NUMBER OF DIABETICS PROPELS THE ADOPTION OF BLOOD GLUCOSE MONITORING DEVICES
5.4 FETAL MONITORING & OBSTETRIC DEVICES
5.4.1 RISE IN THE NUMBER OF PRETERM BIRTHS TO DRIVE THIS SEGMENT
5.5 NEUROMONITORING DEVICES
5.5.1 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE THIS SEGMENT
5.6 SLEEP MONITORING DEVICES
5.6.1 CONTINUOUS MONITORING OF SLEEP PATTERNS HELPS IDENTIFY THE ROOT CAUSE OF SLEEP-RELATED DISORDERS, THEREBY AIDING PROPER DISEASE MANAGEMENT

6 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT (Page No. – 66)
6.1 INTRODUCTION
6.2 PATCHES
6.2.1 EASE OF USE, CONVENIENCE, NON-INVASIVENESS, AND COMPACT DESIGN ARE EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT
6.3 SMARTWATCHES
6.3.1 DATA ACCURACY, LIMITED BATTERY LIFE, AND COMPETITION FROM FITNESS BANDS MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT
6.4 ACTIVITY MONITORS & WRISTBANDS
6.4.1 INCREASING PREVALENCE OF CHRONIC DISEASES HAS RESULTED IN A SIGNIFICANT INCREASE IN THE DEMAND FOR ACTIVITY MONITORS
6.5 OTHER CLINICAL-GRADE WEARABLES

7 CLINICAL-GRADE WEARABLES MARKET, BY END USER (Page No. – 74)
7.1 INTRODUCTION
7.2 LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES
7.2.1 INCREASING NUMBER OF PEOPLE REQUIRING LONG-TERM CARE AS A RESULT OF THE RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
7.3 HOSPITALS
7.3.1 LEADING HOSPITALS ARE USING WEARABLE TECHNOLOGIES TO TRANSFORM RESIDENT TRAINING AND EMERGENCY MEDICINE COMMUNICATION, WHICH PROVIDES THEM WITH A CRITICAL ADVANTAGE
7.4 AMBULATORY CARE CENTERS
7.4.1 THE SHIFT OF PATIENT CARE FROM INPATIENT TO OUTPATIENT SETTINGS IS DRIVING THE GROWTH OF THIS END USER SEGMENT
7.5 HOME CARE SETTINGS
7.5.1 GOVERNMENT INITIATIVES ARE EXPECTED TO SUPPORT THE MARKET GROWTH

8 CLINICAL-GRADE WEARABLES MARKET, BY REGION (Page No. – 80)
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 In 2019, the US accounted for the largest share of the clinical-grade wearables market in North America
8.2.2 CANADA
8.2.2.1 Need to curtail escalating healthcare costs to drive the market in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 Need for better and improved healthcare services will drive the adoption of clinical-grade wearables in Germany
8.3.2 UK
8.3.3 CLINICAL-GRADE WEARABLE DEVICES HAVE WITNESSED HIGH PENETRATION IN THE UK
8.3.4 FRANCE
8.3.4.1 Use of telehealth solutions and services through big data to propel market growth
8.3.5 ITALY
8.3.5.1 Increasing government initiatives for the implementation of eHealth technologies to support market growth
8.3.6 SPAIN
8.3.6.1 Spain has one of the highest levels of mobile phone penetration in Europe
8.3.7 REST OF EUROPE (ROE)
8.4 ASIA PACIFIC
8.4.1 JAPAN
8.4.2 JAPAN IS A HIGHLY DEVELOPED MARKET FOR WIRELESS TECHNOLOGIES WITH A RAPIDLY EVOLVING MOBILE HEALTHCARE SECTOR
8.4.3 CHINA
8.4.4 GROWING FOCUS OF PUBLIC & PRIVATE PLAYERS ON CLINICAL-GRADE WEARABLES DEPLOYMENT IN CHINA TO DRIVE MARKET GROWTH
8.4.5 INDIA
8.4.6 INCREASING NUMBER OF INITIATIVES FROM BOTH GOVERNMENT ORGANIZATIONS AND PRIVATE PLAYERS TO IMPROVE ACCESS TO HEALTHCARE TO DRIVE MARKET GROWTH
8.4.7 REST OF ASIA PACIFIC
8.5 LATIN AMERICA
8.5.1 INCREASE IN THE ADOPTION OF MOBILITY SOLUTIONS IN BRAZIL AND MEXICO TO DRIVE GROWTH IN THE CLINICAL-GRADE WEARABLES MARKET
8.6 MIDDLE EAST & AFRICA
8.6.1 GOVERNMENT INVESTMENTS IN BUILDING A HEALTHCARE MOBILITY FRAMEWORK IN THE MEA REGION TO DRIVE MARKET GROWTH

9 COMPETITIVE LANDSCAPE (Page No. – 123)
9.1 OVERVIEW
9.2 MARKET RANKING ANALYSIS
9.3 COMPETITIVE LEADERSHIP MAPPING, 2019
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 EMERGING COMPANIES
9.3.4 DYNAMIC DIFFERENTIATORS
9.4 COMPETITIVE SITUATION AND TRENDS
9.4.1 NEW PRODUCT LAUNCHES & ENHANCEMENTS
9.4.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
9.4.3 ACQUISITIONS

10 Company profiles (Page No. – 132)
10.1 KONINKLIJKE PHILIPS N.V.
10.1.1 BUSINESS OVERVIEW
10.1.2 PRODUCTS OFFERED
10.1.3 RECENT DEVELOPMENTS
10.1.4 MNM VIEW
10.2 MEDTRONIC PLC
10.2.1 BUSINESS OVERVIEW
10.2.2 PRODUCTS OFFERED
10.2.3 RECENT DEVELOPMENTS
10.2.4 MNM VIEW
10.3 OMRON HEALTHCARE CO., LTD. (A PART OF OMRON CORPORATION)
10.3.1 BUSINESS OVERVIEW
10.3.2 PRODUCTS OFFERED
10.3.3 RECENT DEVELOPMENTS
10.3.4 MNM VIEW
10.4 BIOTELEMETRY, INC.
10.4.1 BUSINESS OVERVIEW
10.4.2 PRODUCTS OFFERED
10.4.3 RECENT DEVELOPMENTS
10.5 APPLE, INC.
10.5.1 BUSINESS OVERVIEW
10.5.2 PRODUCTS OFFERED
10.5.3 RECENT DEVELOPMENTS
10.6 GE HEALTHCARE
6.6.1 BUSINESS OVERVIEW
6.6.2 PRODUCTS OFFERED
6.6.3 RECENT DEVELOPMENTS
10.7 ABBOTT LABORATORIES
10.7.1 BUSINESS OVERVIEW
10.7.2 PRODUCTS OFFERED
10.7.3 RECENT DEVELOPMENTS
10.8 DEXCOM, INC.
10.8.1 BUSINESS OVERVIEW
10.8.2 PRODUCTS OFFERED
10.8.3 RECENT DEVELOPMENTS
10.9 IRHYTHM TECHNOLOGIES, INC.
10.9.1 BUSINESS OVERVIEW
10.9.2 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018)
10.9.3 PRODUCTS OFFERED
10.10 MASIMO CORPORATION
10.10.1 BUSINESS OVERVIEW
10.10.2 PRODUCTS OFFERED
10.11 PREVENTICE SOLUTIONS, INC.
10.11.1 BUSINESS OVERVIEW
10.11.2 PRODUCTS OFFERED
10.11.3 RECENT DEVELOPMENTS
10.12 CONTEC MEDICAL SYSTEMS CO. LTD.
10.12.1 BUSINESS OVERVIEW
10.12.2 PRODUCTS OFFERED
10.13 BIO-BEAT TECHNOLOGIES
10.13.1 BUSINESS OVERVIEW
10.13.2 PRODUCTS OFFERED
10.13.3 RECENT DEVELOPMENTS
10.14 VITALCONNECT
10.14.1 BUSINESS OVERVIEW
10.14.2 PRODUCTS OFFERED
10.14.3 RECENT DEVELOPMENTS
10.15 MINTTIHEALTH
10.15.1 BUSINESS OVERVIEW
10.15.2 PRODUCTS OFFERED
10.15.3 RECENT DEVELOPMENTS
10.16 BIOTRICITY INC.
10.17 VERILY LIFE SCIENCES (A PART OF ALPHABET INC.)
10.18 CYRCARDIA ASIA LIMITED
10.19 TEN3T HEALTHCARE
10.20 VIVALNK, INC.



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医療ウェアラブルの世界市場予測:デバイス別(バイタルサインモニタリング、血圧モニター、グルコースモニター、ECGモニター、パルス酸素濃度計)、製品別(スマートウォッチ、パッチ、リストバンド)、エンドユーザー別(病院、老人ホーム、外来)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆